A 2014 study involving 976 subjects reported similar results (2)
Oct 2010;1(1):110-115
It has been extensively studied for its regenerative effects, particularly in healing soft tissue, reducing inflammation, and improving gut health
Immunogenicity: The FDA classified BPC-157 in Category 2 for bulk drug substances, citing possible safety issues in compounding (immunogenicity, impurities, and insufficient safety evidence for suggested administration routes)
It is helpful to distinguish between four possible outcomes: Reduced breakage Less shedding Thicker-looking strands Increased hair density or new growth A peptide product may help with one outcome without producing all four
OCT embedded brains were cut into 10 m sections, the sections were rinsed three times with PBS, blocked for 1 h in 8% bovine serum albumin (BSA) dissolved in 0.01 M phosphate buffer (PB) containing 0.5% Triton-X100